Background: Estrogen receptor beta (ER ) activation has been shown to be cardioprotective, but the involved cell types and mechanisms are not understood. To investigate whether ER restricted to cardiomyocytes contributes to observed cardioprotection, we tested the effects of a cardiomyocyte-specific ER overexpression (ER -OE) on survival, cardiac remodelling and function after myocardial infarction (MI) and studied potentially involved molecular pathways. Methods and Results: Female and male mice with cardiomyocyte-specific ER -OE and wild type (WT) littermates were subjected to chronic anterior coronary artery ligation or sham surgery. Two weeks after MI, ER -OE mice showed improved survival (100 and 83% vs 76 and 58% in WT females and males respectively). ER -OE was associated with attenuated left ventricular (LV) dilatation, smaller increase in heart weight, less lung congestion at similar MI size, and improved systolic and diastolic function in both sexes. We identified two potential pathways for ER mediated myocardial protection. First, male and female ER -OE mice had a lower reduction of SERCA2a expression after MI, suggesting less reduction in diastolic Ca 2+ -reuptake into sarcoplasmic reticulum post MI. Second, male ER -OE revealed attenuated cardiac fibrosis in the remote LV tissue and expression of fibrosis markers Col I, Col III, periostin, and miR21. Conclusions: Cardiomyocyte-specific ER -OE improved survival associated with reduced maladaptive remodelling, improved cardiac function and less heart failure development after MI in both sexes. These effects seem to be related, at least in part, to a better maintenance of Ca 2+ -cycling in both sexes and a lower induction of cardiac fibrosis in males after MI.
Introduction
Sex has an important impact on cardiac remodelling, which is defined as changes in structure, dimensions and physiology of the heart after injury [1] . In response to myocardial infarction (MI), women experience less adverse left ventricular (LV) remodelling than men, resulting in better preservation of LV size and function [2, 3] . In animal models of MI, female mice showed improved survival, maladaptive remodelling and cardiac function compared to males [4] . These differences between sexes have been widely related to the sex hormone estrogen. Estrogen-effects are mainly mediated by two cognate receptors, ER and ER , which are expressed in the myocardium of males and females in a broad variety of species ranging from mice to human [5] [6] [7] [8] . Albeit both ER subtypes activate a variety of signal transduction pathways [9, 10] , functions of the individual ER subtypes are still not completely understood. The development of transgenic and knock-out animal models has helped so far to elucidate this important issue.
Studies using mouse models to analyze the role of ER in MI pointed to a protective role of ER in female mice. Pelzer et al. [11] showed increased mortality and aggravated clinical and biochemical markers of heart failure (HF) in systemic ER knock-out (ER -/-) female mice after experimental MI. Korte et al. [12] observed impaired repolarization and automaticity in female mice post-MI, and Babiker et al. [13] observed increased MI size among female ER -/-mice. The molecular basis for the observed cardioprotective effects of ER after MI needs further investigation. Pelzer et al. observed an impairment of calcium-handling proteins in female ER -/-mice [11] . In a model of pressure overload using systemic ER knock-out (ER -/-) mice, we recently showed that ER attenuates the development of LV fibrosis [14] . Furthermore, activation of specific myocardial hypertrophy associated signalling pathways has been shown to be cardioprotective [15] . For instance, increased PI3-K-AKT activity led to improved survival in a mouse model of dilated cardiomyopathy and to favourable effects on cardiac function and remodeling [16, 17] . We and others showed that cardioprotective signalling pathways are modulated by ER [18, 19] .
The effects of ER in the male sex after MI have not been studied yet. Furthermore, using systemic knock out models, it has not been clarified whether systemic or cardiac specific effects of ER confer cardioprotection. In the present study, we therefore used a cardiomyocyte-specific ER overexpression (ER -OE) mouse model which allowed the analysis of cardiac effects of ER independently of systemic effects on both sexes subjected to MI. The main hypothesis of this study was that a cardiomyocyte-specific ER -OE attenuates pathological myocardial remodelling and preserves cardiac function after MI in both sexes.
Materials and Methods

Generation of transgenic mice
A novel transgenic mouse model with cardiomyocyte-specific ER -OE was generated. Inducible double transgenic mice with cardiomyocyte-specific ER -OE were generated through mating of monotransgenic mouse ER (tetO-mER ) and monotransgenic -MHCtTA mice using Tet-Off system (details online supplement). Male and female ER -OE and WT mice with B6D2F background were used.
Induction of myocardial infarction
Experiments were conducted in accordance with the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication No. 85-23, revised 2011) and with the guidelines of the State Agency for Health and Social Affairs (LaGeSo, Berlin, Germany, G0246/12). Female and male ER -OE and WT littermates aged 10-12 weeks, were randomly assigned to MI or sham surgery. MI was induced in female and male mice by permanent left anterior descending coronary artery ligation. Briefly, after induction of anesthesia (ketamine hydrochloride 80mg/ml and xylazine hydrochloride 12mg/ml by intraperitoneal injection at a dose of 1mg/kg), mice were intubated and ventilated (respirator: Hugo Basile model; FMI). After exposing the left anterior descending coronary artery through a 4 th intracostal left lateral thoracotomy, the artery was permanently ligated with a 7.0 polypropylene suture at a distance of 1-2 mm from the left auricle. Sham animals underwent the same surgical procedure but the ligature was not tied. Animals were treated with rimadyl (5mg/kg) for analgesia up to 7 days post-surgery.
High resolution echocardiography
Echocardiography was performed under isoflurane anesthesia one day before and 2 weeks after surgery with a Vevo 770 (VisualSonics, Toronto, Canada) [14] equipped with a 20-55 MHz transducer. Anaesthesia was induced with isoflurane 3% and maintained with isoflurane 1.5%. Body temperature was maintained through a heating pad at 37°C. Electrocardiogram and respiration were monitored during echocardiography. Images and cineloops were acquired for further off-line analysis by a single operator blinded for genotype, sex and operation. LV enddiastolic and endsystolic volumes (LVEDV, LVESV), mean wall thickness, and ejection fraction (EF) were determined by tracing of endocardial and epicardial borders and majors in enddiastole and in endsystole in the parasternal long axis view. Transmitral flow-analysis from the four chamber view was used to characterize diastolic function from the following parameters: peak E and A waves, E wave deceleration time and filling interval. Pulsed-wave Doppler measurements were made at the ascending aorta level for the determination of ejection time and LV pre-ejection time, and at the origin of the pulmonary artery for the determination of right ventricular pre-ejection time. The difference between the electromechanical ejection delay of the LV (duration from the QRS complex to the beginning of the aortic outflow) and of the right ventricular (duration from de QRS complex to the beginning of the pulmonary outflow) was used as an index of interventricular asynchrony [20] . Tissue Doppler imaging (TDI) systolic S and diastolic E' wave from the septal side of the mitral annulus were measured and the ratio transmitral E to mitral annulus E' was calculated. The myocardial performance index [(filling interval -ejection time)/ejection time] was calculated as an index of global systolic and diastolic function.
Infarct size determination MI size was determined by echocardiography based on LV wall motion according to the method used in clinical routine in humans [21] . Since the development of high resolution ultrasound machines, echocardiographic analysis is recognized as a precise and noninvasive evaluation technique for LV morphology and function in small animals [22, 23] . An additional advantage is the preservation of LV tissue for molecular analysis in the same cohort of animals. Echocardiographic evaluation of MI size has been shown to strongly correlate with histologic determination (r=0.96) [24] and with LV systolic dysfunction (r=0.94) [25] . We used the Electrocardiogram-Gated Kilohertz Visualization™-mode which A c c e p t e d M a n u s c r i p t synthesizes high temporal resolution B-Mode images by combining Electrocardiogramsynchronized heart cycles, thus producing sequences at up to 1000 frames per second. The synthesized cycle was displayed in slow motion before tracing endocardial perimeters at enddiastole. As shown in Fig. 1A , MI size was determined from the long axis view obtained with a high definition in mice. MI size (%) was calculated [24] as the internal perimeter of the infarcted region, identified by a thinned akinetic wall, in relation to the total perimeter of the LV cavity: MI (%) = MI perimeter/(MI perimeter + normal endocardial perimeter)x100. For comparison, MI size was also determined as the mean from 4 different short axis views at basal, papillary, mid-ventricular and apical LV level (Fig. 1B) which show horizontal views of the ventricle. Fig. 1C shows a high correlation between MI size determined from long and short axis views (r² = 0.94; p<0.0001, n=67). As small infarcts induce no global or only minimal regional remodeling, only animals with an MI size > 20% in the MI groups were included.
Tissue sampling
Mice that died before the end of the observation period were subjected to autopsy, and heart and lungs were examined. Two weeks after MI, surviving mice were anesthetized with isoflurane (1.5%) and killed by cervical dislocation. Hearts were harvested, LV isolated, immediately snap frozen in liquid nitrogen and stored at -80°C or fixed in 4% formaldehyde for at least 24h; until use for gene and protein or histological analyses.
Cell morphology
Adult mouse ventricular cardiomyocytes were isolated as described previously [26] . Individual length and width of the cardiomyocytes were determined on micrographs captured by Axiovert 40 CFL microscope (using objective: N-Achroplan 10x/0.25 Ph1 W 0.8) and digitalized by AcioCam MR3 camera. Ten micrographs per sample were randomly taken, and 300 to 500 rod-shaped myocytes were measured per sex and genotype. Length and width of cardiomyocytes were determined at the widest point of each cell using the software program "AxioVision Release 4.8" (Zeiss).
Quantitative real-time polymerase chain reaction Total RNA isolation from LV tissue and quantitative real-time polymerase chain reaction were conducted as described before [18, 14] . The primers used for quantification of relative gene expression of mouse collagen I and III (Col1A2, Col3A1), atrial natriuretic peptide A (NPPA), myosin heavy chain (Myh) 6, Myh7, microRNA (miR)-21, miR-24, miR-27a, miR-106a are listed in supplemental table 1. Gene expression levels were normalized to 50S ribosomal protein L15 (RPLO) and the amount of miRNAs was normalized using the average of the expression of RNU6B and RNU1A.
Western blot analysis
Analysis was performed as described before [6] . The following primary antibodies were used: ER (G-20, Santa Cruz); ER (SP5198P, Acris); periostin (S-15, Santa Cruz); sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (ATP2A2/SERCA2a, SM5113, Acris); phospholamban (PLN, SAB2701037, Sigma-Aldrich); phospho-phospholamban (p-PLN, sc-17024-R, Santa Cruz); phospho-p44/p42 ERK1/2 (Thr202/Tyr204) (#4370, Cell Signaling Technology); p44/p42 ERK1/2 (#4695, Cell Signaling Technology); phosphoSerin/Threonin-kinase (AKT1/2/3) (Ser 473-R, Santa Cruz); AKT1/2/3 (H-136, Santa Cruz); -tubulin (clone DM1A, Sigma) and GAPDH (MAB374, Millipore).
Histological analysis and Immunofluorescence
LV sections were stained with Sirius-red to determine collagen deposition as previously described [18] . Fibrosis in remote area was calculated as the ratio of fibrotic area (excluding the MI zone) to total myocardial area in the remote zone. For immunofluorescence, paraffinembedded sections were incubated with anti-mouse ER antibody (Acris SP5198P) followed by secondary Fluorescein isothiocyanate-conjugated anti-mouse IgG (Jackson ImmunoResearch Laboratories), as described before [7] . Nuclei were stained with 6-diamidino-2-phenylindole (DAPI). Confocal images were acquired using Leica TCS-SPE spectral confocal laser scanning microscope.
Statistical analysis
Data are shown as mean ± standard error of the mean (SEM). The differences between groups were tested by using ANOVA as appropriate. Three-way ANOVA was used to analyze interactions between operation, genotype and sex, followed by PLSD Fisher posttest to independently assess the overall effect of operation (MI vs sham), genotype (ER -OE vs WT) or sex (male vs female). Two-way ANOVA was used to test the influence of operation independent of genotype, and of genotype independent of sex, followed by Bonferroni post hoc test using GraphPad Prism 5.01. MI Mortality was illustrated by Kaplan-Meier curves and analysed by log-rank test. Peri-procedural deaths within the first 24 hours after the operation were excluded. P 0.05 were considered statistically significant.
A c c e p t e d M a n u s c r i p t
Results
Characterization of ER -OE mice
There were no differences in heart weight, LV morphology, cardiac function (supplemental  table 2 ) and cardiomyocyte size ( Fig. 2A ) between ER -OE and WT mice at basal level. ER protein was significantly higher in whole protein lysate from LV of ER -OE compared to WT mice (female: 1.8 fold and male: 1.5 fold; Fig. 2B ). ER -OE in the LV was confirmed by immuno-fluorescence (Fig. 2C ). ER -OE was specific to the heart, and ER expression did not increase in kidney, soleus and uterus of ER -OE mice (supplemental Fig. 1 ). There was no change of ER protein expression in LV tissues (Fig. 2D ). Blood serum estradiol levels were not different between ER -OE and WT mice (supplemental results).
ER -OE reduces mortality rate after myocardial infarction ER -OE significantly reduced mortality compared to WT mice after MI ( Fig. 3 ; p=0.008). The survival rate 2 weeks after MI was 100 and 83% in ER -OE, and 76 and 58% in WT female and male mice, respectively. Female and male WT mice that died before the end of the observation period showed 25 and 50% of cardiac rupture respectively, with a peak at day 3.8±0.8, whereas no rupture was observed in ER -OE mice. Cardiac rupture was indicated by blood coagula in the chest cavity and small slits commonly observed at the LV free wall. After day 4, only female and male WT mice died, showing signs of pulmonary congestion at autopsy.
ER -OE attenuates LV maladaptive remodelling
After MI, LV mean wall thickness was reduced due to the thinned infarcted myocardial wall, whereas LV volumes increased (table 1) . ER -OE did not affect MI size, but was associated with reduced LV maladaptive dilatation. ER -OE mice had a smaller increase of LVEDV and LVESV with a sex-genotype-surgery interaction for both parameters after MI (table 1) . ER -OE was also associated with a smaller increase in heart and lung weight normalized for tibia length with a genotype-surgery interaction. WT mice had not only higher heart but also higher lung weight, indicating a more advanced stage of HF compared to ER -OE. Separate analysis in each sex after MI showed a significant ER -OE effect on LV volumes only in males ( Fig. 4A ).
ER -OE preserves LV systolic and diastolic function after MI
MI surgery significantly reduced parameters of systolic and diastolic function (table 1) . ER -OE was associated with a smaller decrease of EF, tissue Doppler S wave and with lower interventricular asynchrony in both sexes. ER -OE mice also showed a better preserved diastolic function after MI, as indicated by TDI E wave, E wave deceleration time, E/E' ratio and a better preservation of myocardial performance index. A genotype-surgery interaction was observed for all functional parameters. Separate analysis in each sex after MI showed a significant ER -OE effect on TDI S and diastolic parameters both in females and males (Fig.  4B ), whereas the effect on EF was only significant in males (Fig. 4A) .
Effect of ER -OE on hypertrophy markers after MI
MI significantly induced NPPA mRNA in the LV remote area compared to sham (MI vs Sham; p<0.0001). Separate analysis in each sex after MI showed that ER -OE significantly attenuated NPPA expression after MI only in male mice (supplemental Fig. 2A ). Myh6/Myh7 ratio revealed no significant change after MI (supplemental Fig. 2B ). Further, measurement of signaling pathways involved in cardioprotection [17, 27] , i.e. phosphorylation of AKT (p-AKT) and ERK1/2 (p-ERK1/2) showed no significant changes after MI (supplemental Fig. 2C -D).
ER -OE attenuates the development of cardiac fibrosis and the expression of fibrosis markers
MI induced an increase of cardiac fibrosis in the LV remote area associated with increased expression of Col I and Col III mRNA, miR21 and periostin protein (MI vs Sham; p<0.0001 for A c c e p t e d M a n u s c r i p t all parameters). ER -OE was associated with lower fibrosis and reduced expression of Col I and III (ER -OE vs WT; p<0.05 for all three parameters). Separate analysis in each sex after MI showed that the ER -OE effect on fibrosis, Col I, and Col III reduction was significant only in males (Fig. 5A-5D ). In addition, miR-21 expression and periostin protein were not significantly increased in male ER -OE compared with male WT after MI (Fig. 5E-5F ). Levels of miR-24, miR-27a and miR-106a revealed no significant alteration after MI (supplemental Fig. 3 ). Inflammatory marker levels (Interleukin-6; tumor necrosis factor alpha; TYRO protein tyrosine kinase-binding protein and Fc receptor IgE high affinity I gamma polypeptide targeted mutation 1) were not significantly different between ER -OE and WT mice two weeks post-MI (data not shown).
ER -OE improves the expression of calcium-handling proteins
MI significantly reduced SERCA2a protein expression in the LV remote area compared to sham (p<0.0001). ER -OE was associated with significant higher expression of SERCA2a compared to WT (p<0.0001). Separate analysis in each sex showed that SERCA2a levels were significantly higher in female and male ER -OE compared to WT after MI (Fig. 6A) . The ratio of phosphorylated PLN to total PLN showed no significant difference between MI groups (Fig. 6B) .
Discussion
Cardioprotective effects of ER , particularly in females, have been reported. However, mechanistic understanding is limited and it was not possible to separate ER systemic effects from cardiac effects. We now show for the first time that cardiomyocyte-specific ER -OE led to improved survival, reduced LV remodelling, and better cardiac function in male and female mice two weeks after MI.
ER -OE effect on survival
Cardiomyocyte-specific ER -OE significantly improved survival two weeks after MI. Interestingly, we observed no LV rupture in ER -OE mice during the early phase after MI. This might be associated with decreased early LV remodeling and inflammation. However, our study was not an acute study and two weeks after MI we could not show any difference in inflammatory markers. The investigation of mechanisms associated with the reduction of rupture by ER -OE will be of high interest for future studies. In contrast to WT mice, all ER -OE mice survived after day 4. No heart failure associated deaths were observed in ER -OE animals and this can be related to reduced LV remodelling and to improved systolic and diastolic function. Long term pro-survival effects of ER in female mice have also been suggested by loss of function studies with increased mortality in female ER -/- [12, 11, 13, 14] , associated with an increase in heart failure markers [11] . Data from our study show improved survival after MI in females by ER -OE, underscoring the beneficial role of ER in females. However, our findings on improved survival by ER -OE in males are completely novel, and may reveal an interesting pathway for cardioprotection in males. In contrast to studies with systemic modulation of ER , our study is based on a cardiomyocyte-specific approach. We can thus exclude the contribution of systemic effects.
ER -OE effect on MI size, LV remodelling and cardiac function
Improved survival and reduced maladaptive remodelling in ER -OE mice were not related to a different MI size compared to WT. These results are in accordance with previous studies of Korte et al. and Pelzer et al. who observed no change in MI size in ER -/-females [12, 11] . After MI, ER -OE in cardiomyocytes induced a smaller increase of LV enddiastolic and endsystolic volumes, and a smaller decrease of EF compared to WT. Parameters of myocardial function like TDI S and E' wave, reflecting intrinsic myocardial relaxation and contraction, showed a significantly better preservation in ER -OE mice. ER -OE was also associated with a lower increase of interventricular asynchrony. Cardiac asynchrony, due to asynchronous contraction between the right ventricle and the infarcted LV, is an important prognostic marker in patients after MI for survival, cardiac remodelling and function [20] . Diastolic parameters like E wave deceleration time and the E/E' ratio were significantly less impaired in ER -OE mice, indicating less increased LV filling pressures. This is in agreement with the observation of lower lung weight in ER -OE, suggesting attenuated HF compared to WT. Finally, the myocardial performance index, a global marker of systolic and diastolic function was significantly less increased in ER -OE, indicating higher global efficiency.
Although most of these functional parameters were improved in females and males by ER -OE, the effect on LV volumes and on EF was more pronounced in males compared to females. This difference seems to be due, at least in part, to the fact that male WT showed worse maladaptive remodelling and thus benefited most from ER -OE.
Molecular mechanism of ER induced cardioprotection
This study identified two molecular pathways by which ER might contribute to cardioprotection. First, we observed a lower reduction of SERCA2a protein expression in male and female ER -OE after MI compared to WT mice. In human and experimental heart failure a diminished Ca 2+ uptake resulting from decreased expression/activity of SERCA2a is recognized as a hallmark of heart failure [28] . In cardiomyocytes, SERCA2a plays a central role in Ca 2+ cycling required for both relaxation and contraction [29] . SERCA2a transports Ca 2+ from the cytosol into the sarcoplasmic reticulum (SR), thereby contributing to the low diastolic Ca 2+ levels required for relaxation and replenishing Ca 2+ stores needed for the next contraction [30] . While SERCA2a homozygous knockout mice (SERCA2a -/-) die early in A c c e p t e d M a n u s c r i p t development, heterozygous SERCA2a mice (SERCA2a +/-) showed decreased myocyte contractility and SR Ca 2+ load, resulting to heart failure in combination with an increased hemodynamic load [31, 30] . On the other hand, a SERCA2a overexpression in the heart of transgenic mice accelerates calcium transients and cardiac relaxation resulting in higher cardiac contractility [32, 33] . In our study, a better reuptake of calcium from the cytosol to the SR via an increased expression of the calcium-ATPase during diastole might explain a better myocardial relaxation, as indicated by improved TDI E' in ER -OE as compared to WT mice. Increased SR calcium content due to higher SERCA2a expression might in turn explain a more important calcium release via the ryanodine receptors and an increase of the calcium transient during systole. This could contribute to better intrinsic contraction as indicated by improved TDI S and better global myocardial performance as observed in ER -OE males and females. Improved Ca 2+ -cycling between SR and the cytosol might thus constitute a mechanism of cardioprotection mediated by ER .
Second, reduced maladaptive remodelling observed with ER -OE was associated with lower cardiac fibrosis and expression of fibrosis markers after MI, particularly in male mice. Post-infarct LV remodelling is due to infarct expansion but also to remodelling processes in the remote zone. While healing of the infarct zone with a firm fibrous scar is essential for chamber integrity, exaggerated fibrosis in the remote zone can lead to maladaptive remodelling, thus contributing to cardiac dysfunction [34] . Attenuated cardiac fibrosis in male ER -OE might be therefore one underlying reason for significantly less maladaptive remodelling and better EF (as a volume-dependent parameter). ER -OE in female hearts did not attenuate fibrosis after MI compared to female WT, which might be due to the fact that females develop less fibrosis compared to male WT-mice [14] . Further, Pelzer et al. [11] showed also no ER -mediated modulation of the myocardial collagen content in female ER -/-compared to WT females after MI. Sex specific antifibrotic effects of ER have already been described in different mouse models, e.g. pressure overload induced myocardial hypertrophy. Our recent studies showed ER -mediated sex-specific cardiac remodelling in a pressure overload induced mouse model and in miRNA regulation involved in cardiac fibrosis development [14, 35] .
Reduced fibrosis and expression of fibrosis markers in male ER -OE mice may be mediated by reduction of miR-21 expression. Silencing of miR-21 in different HF models led to the suppression of cardiac fibrosis, collagen and periostin expression and attenuation of cardiac dysfunction [36] [37] [38] . ER -mediated down-regulation of miRNA21 has been described by us and others [35, 39] and could have contributed to antifibrotic effects in male ER -OE mice. These data indicate that ER plays an important role in the development of fibrosis in male sex after MI.
Study limitations
An overexpression model, as a gain of function model, does not exactly reflect the ER effect in a physiological setting. However, it may illustrate the potential effects of specific ER agonists on cardiomyocytes. Further studies are necessary to study the effects of ER in the setting of acute MI, including in particular the pathways associated with LV rupture during the early phase post-MI, which was reduced by ER -OE. Although our model was based on a cardiomyocyte-specific approach, we cannot exclude the involvement of other cardiac cell types. Cellular cross-talk between cardiomyocytes and fibroblasts in particular might have contributed to the observed effects on fibrosis. Further mechanistic studies are necessary to investigate the role of this cellular cross talk.
Clinical perspectives
i) The lower incidence of ischemic cardiomyopathy in premenopausal women compared to age-matched men raises the crucial question about the mechanisms of estrogen and estrogen receptor mediated cardioprotection, which is incompletely understood. In experimental models, ER activation has been shown to be cardioprotective, but involved cell types and mechanisms are unclear.
(ii) In the present study, cardiomyocyte-specific overexpression of ER in the setting of chronic MI induced improved survival in mice of both sexes and was associated with less maladaptive LV remodelling, better cardiac function and less HF development. (iii) Overexpression of ER in cardiomyocytes conferred significant cardioprotective effects, which may lead to the development of therapies that selectively enhance beneficial ER effects in female and male hearts. Subtype-selective estrogen receptor modulators are already used in clinical practice or are currently tested for the treatment of breast cancer and osteoporosis [40] and may also be of interest in the treatment of cardiac diseases.
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